Cell Culture Bioreactors

Cell Culture Technology for Pharmaceutical and Cell-Based Therapies

Volumn , Issue , 2005, Pages 155-224

  Fenge, Christel ^a   Elke Lullau ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85135000347     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780849351068-9     Document Type: Chapter

References (515)

1. Harrison RG. Observations on the living developing nerve fiber. Proc Soc Exp Biol Med 1907; 4:140-143.
2. Carrel A. On the permanent life of tissues outside the organism. J Exp Med 1912; 15:516-528.
3. Griffiths JB. Advances in animal cell immobilization technology. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 4. New York: Academic Press1990:149-166.
4. Spier RE, Kadouri A. The evolution of processes for the commercial exploitation of anchorage-dependent animal cells. Enzyme Microb Technol 1997; 21:2-8.
5. Finter NB. Animal cell culture: the problems and rewards. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:3-12.
6. Scheirer W. Animal cell immobilization. In: Durant G, Bobichon L, Florent J, Eds. 8th International Biotechnology Symposium. Paris: Avignon 1988:216-227.
7. Sinclair A. Biomanufacturing capacity: current and future requirements. J Commercial Biotechnol 2001; 8(1):43-50.
8. Nyberg SC, Shatford RA, Peshwa MV, White JG, Cerra F, Hu WS. Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liver. Biotechnol Bioeng 1993; 41:194-203.
9. Hu WS, Friend JR, Wu FJ, Sielaff T, Peshwa MV, Lazar A, Nyberg SL, Remmel RP, Cerra FB. Development of a bioartificial liver employing xenogenic hepatocytes. Cytotechnology 1997; 23(1):29-38.
10. Maki T, Otsu I, O’Neil JJ, Dunleavy K, Mullon CJP, Solomon BA, Monaco AP. Treatment of diabetes by xenogenic islets without immunosuppression: use of a vascularized bioartificial pancreas. Diabetes 1996; 45:342-347.
11. Pörtner R, Rössing S, Stange J, Fassnacht D. Fixed-bed reactors for animal cell culture cultivation: an approach to artificial organs. In: Merten O-W, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordrecht:Kluwer Academic Publishers, 1998:657-659.
12. Yanagi K, Moyoshi H, Ohshima N. Improvement of metabolic performance of hepatocytes cultured in vitro in a packed-bed reactor for use as a bioartificial liver. J ASAIO 1998:M436-M440.
13. Moussy Y. Bioartificial kidney. I. Theoretical analysis of convective flow in hollow fiber modules: application to a bioartificial hemofilter. Biotechnol Bioeng 2000; 68(2):142-152.
14. Collins PC, Nielsen LK, Patel SD, Papoutsakis ET, Miller WM. Characterization of hematopoietic cell expansion, oxygen uptake, and glycolysis in a controlled, stirredtank bioreactor system. Biotechnol Prog 1998; 14(3):466-472.
15. Carswell KS, Papoutsakis ET. Culture of human T cells in stirred bioreactors for cellular immunotherapy applications: shear, proliferation, and the IL-2 receptor. Biotechnol Bioeng 2000; 68(3):328-338.
16. Boyd JE, Borland L, Fisher CE. Scale-up and optimisation issues in gene therapy viral vector production. In: Merten O-W, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordrecht: Kluwer Academic Publishers, 1998:657-675.
17. Ostrove JM, Iyer P, Marshall J, Vacante D. Comparison of manufacturing techniques for adenovirus production. In: Merten O-W, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordrecht: Kluwer Academic Publishers, 1998:515-521.
18. Iyer P, Ostrove JM, Vacante D. Comparison of manufacturing techniques for adenovirus production. Cytotechnology 1999; 30(1-3):169-172.
19. Merten OW, Cruz PE, Rochette C, Geny-Fiamma C, Bouquet C, Goncalves D, Danos O, Carrondo MJT. Comparison of different bioreactor systems for the production of high titer retroviral vectors. Biotechnol Prog 2001; 17(2):326-335.
20. De Bruyne NA. The design of bench-scale reactors. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 3. New York: Academic Press, 1988:141-176.
21. Spier RE, Griffiths B. An examination of the data and concepts germane to the oxygenation of cultured animal cells. Dev Biol Stand 1984; 55:81-92.
22. Shirokaze J, Nogawa M, Ogura R. High density culture macroporous microcarrier. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:261-263.
23. Heidemann R, Riese U, Lutkemeyer D, Buntemeyer H, Lehmann J. The Super-Spinner:a low cost animal cell culture bioreactor for the CO2 incubator. Cytotechnology 1994; 14(1):1-9.
24. Selander M, Hassel J, Dartsch Ch, Fenge C, Lüllau E. Characterisation and evaluation of a new screening system for animal cell culture. In: Lindner-Olsson E, Lüllau E, Chatzisavido N, eds. Animal Cell Technology: From Target to Mark. Proceedings of the 17th ESACT Meeting 2001. Dordrecht: Kluwer Academic Publishers, 2002:341-343.
25. Goosen MFA. Insect cell cultivation techniques for the production of high-valued products. Can J Chem Eng 1991; 69:450-456.
26. Martinelle K, Doverskog M, Jacobsson U, Chapman BE, Kuchel PW, Häggström L. Elevated glutamate dehydrogenase flux in glucose-deprived hybridoma and myeloma cells: evidence from 1H=15N NMR. Biotechnol Bioeng 1998; 60(4):508-517.
27. Cowger NL, O’Connor KC, Hammond TG, Lacks DJ, Navar GL. Characterization of bimodal cell death of insect cells in a rotating-wall vessel and shaker flask. Biotechnol Bioeng 1999; 64(1):14-26.
28. Hunt L, Batard P, Jordan M, Wurm F. Fluorescent proteins in animal cells for process development: optimization of sodium butyrate treatment as an example. Biotechnol Bioeng 2002; 77(5):528-537.
29. Weiss S, John GT, Klimant I, Heinzle E. Modeling of mixing in 96-well microplates observed with fluorescence indicators. Biotechnol Prog 2002; 18:821-830.
30. Hermann R, Lehmann M, Büchs J. Characterization of gas-liquid mass transfer phenomena in microtiter plates. Biotechnol Bioeng 2003; 81(2):178-186.
31. Palomares LA, Ramirez OT. Bioreactor scale-down. In: Spier RE, ed. Encyclopedia of Cell Technology. Vol. 1. New York: Wiley, 2000:174-183.
32. Singh V. Disposable bioreactor for cell culture using wave-induced agitation. Cytotechnology 1999; 30(1-3):149-158.
33. Reuveny S, Velez D, Miller L, MacMillan JD. Comparison of cell propagation methods for their effect on monoclonal antibody yield in fermentors. J Immunol Methods 1986; 86:61-69.
34. Schürch U, Cryz SJ Jr, Lang AB. Human hybridoma producing antibodies to pseudomonas aeruginosa: scale up and optimization of IgM production in stirred bioreactors. 198 Fenge and Lüllau In: Spier RE, Griffiths IB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:336-341.
35. Bödeker BGD, Newcomb R, Yuan P, Braufman A, Kelsey W. Production of recombinant factor VIII from perfusion culture: I. Large-scale fermentation. In: Spier RE, Griffiths IB, MacDonald C, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:580-583.
36. Griffiths B. Animal cell products, overview. In: Spier RE, ed. Encyclopedia of Cell Technology. Vol. 1. New York: Wiley, 2000:70-76.
37. Aunins J. Viral vaccine production in cell culture. In: Spier RE, ed. Encyclopedia of Cell Technology. Vol. 2. New York: Wiley, 2000:1182-1217.
38. Werner RG. Potential and efficiency in the biotechnical process. Pharm Technol Europe 1994; 20-28.
39. Henzler H.-J. Verfahrenstechnische Auslegungsunterlagen fur Rührbehälter als Fermenter. Chem-Ing-Tech 1982; 54(5):461-476.
40. Reuss M. Stirred tank bioreactors. In: Asenjo JA, Merchuk JC, eds. Bioreactor System Design. New York: Marcel Dekker, 1995:207-255.
41. Prokop A, Rosenberg MZ. Bioreactor for mammalian cell culture. In: Fiechter A, ed. Vertebrate Cell Culture II and Enzyme Technology. Advances in Biochemical Engineering= Biotechnology. Vol. 39. Berlin: Springer-Verlag, 1989:29-71.
42. Fenge C, Klein C, Heuer C, Siegel U, Fraune E. Agitation, aeration and perfusion modules for cell culture bioreactors. Cytotechnology 1993; 11:233-244.
43. Nienow AW, Langheinrich C, Stevenson NC, Emery AN, Clayton TM, Slater NKH. Homogenisation and oxygen transfer rates in large agitated and sparged animal cell bioreactors: Some implications for growth and production. Cytotechnology 1996; 22:87-94.
44. Palomares LA, Ramirez OT. Bioreactor scale-up. In: Spier RE, ed. Encyclopedia of Cell Technology. New York: Wiley, 2000:182-201.
45. Doran PM. Bioreactors, stirred tank. Spier RE, ed. Encyclopedia of Cell Technology. Vol. 1. New York: Wiley, 2000:249-278.
46. Varley J, Birch J. Reactor design for large scale suspension animal cell culture. Cytotechnology 1999; 29(3):177-205.
47. Nienow A. Gas dispersion performance in fermenter operation. Chem Eng Prog 1990; 86(2):61-71.
48. Henzler HJ, Kauling DJ. Oxygenation of cell cultures. Bioprocess Eng 1993; 9:61-75.
49. Feder J, Tolbert WR. The large-scale cultivation of mammalian cells. Sci Am 1983; 248:24-31.
50. Kamen AA, Tom RL, Caron AW, Chavarie C, Massie B, Archambault J. Culture of insect cells in a helical ribbon impeller bioreactor. Biotechnol Bioeng 1991; 38:619-628.
51. Jolicoeur M, Chavarie C, Carreau PJ, Archambault J. Development of helical-ribbon impeller bioreactor for high-density plant cell suspension culture. Biotechnol Bioeng 1992; 39:511-521.
52. Johnson M, André G, Chavarie C, Archambault J. Oxygen transfer rates in a mammalian cell culture bioreactor equipped with a cell-lift impeller. Biotechnol Bioeng 1990; 35:43-49.
53. Shi Y, Ryu DDY, Park SH. Performance of mammalian cell culture bioreactor with a new impeller design. Biotechnol Bioeng 1992; 40:260-270.
54. Girard HC, Okay G, Kilvilcim Y. Use of the vibrofermenter for multiplication of BHK cells in suspension and for replication of FMD virus. Bull Off Int Epiz 1973; 79:805-822.
55. Thalmann E, Berg GJ, Kopp TJ. Kinetics of BHK-21 cells in a bioreactor with a new aeration system through a mesh (CHEMCELL). Dechema Biotechnology Conferences 2. VCH Verlagsgesellschaft, 1988:3-11.
56. Blasey HD, Brethon B, Hovius R, Vogel H, Tairi AP, Lundström K, Rey L, Bernard AR. Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System. Cytotechnology 2000; 32:199-208.
57. Monahan PB, Holtzapple MT. Oxygen transfer in a pulse bioreactor. Biotechnol Bioeng 1993; 42:724-728.
58. Jäger J, Büntemeyer H, Lehmann J. Increasing the rate of production of monoclonal antibodies by combining a stirred reactor with a hollow fiber perfusion system. In: Neijssel OM, van der Meer RR, Lüyben KChAM, eds. Proceedings of the 4th European Congress on Biotechnology. Amsterdam: Elsevier Scientific Publishers, 1987:581-584.
59. Lehmann J, Vorlop J, Büntemeyer H. Bubble-free reactors and their development for contiuous culture with cell recycle. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 3. New York Academic Press, 1988:221-237.
60. Vorlop J, Lehmann J. Scale-up of bioreactors for fermentation of mammalian cell cultures, with special reference to oxygen supply and microcarrier mixing. Chem-Ing-Tech 1988; 11:171-178.
61. Midler M Jr, Finn RK. A model system for evaluating shear in the design of stirred fermentors. Biotechnol Bioeng 1966; 8:71-84.
62. Hu WS. Quantitative and Mechanistic Analysis of Mammalian Cell Cultivation on Microcarriers. Ph.D. Thesis, Massachusetts Institute of Technology, Cambridge, MA, 1983.
63. Kolmogorov ANCR. Dokl Acad Sci USSR 1941; 30:301-305.
64. Cherry RS, Papoutsakis ET. Hydrodynamic effects on cells in agitated tissue culture reactors. Bioprocess Eng 1986; 1:29-41.
65. Cherry RS, Papoutsakis E. Understanding and controlling fluid-mechanical injury of animal cells in bioreactors. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 4. New York: Academic Press, 1990:71-121.
66. Kunas KT, Papoutsakis ET. Damage mechanisms of suspended animal cells in agitated bioreactors with and without bubble entrainment. Biotechnol Bioeng 1990; 36:476-483.
67. Griffiths JB. Overview of cell culture systems and their scale-up. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 3. New York: Academic Press, 1988:179-220.
68. Oh SKW, Nienow AW, Al-Rubeai M, Emery AN. The effects of agitation intensity with and without continuous sparging on the growth and antibody production of hybridoma cells. J Biotechnol 1989; 12:45-62.
69. zMurhammer DW, Goochee CF. Sparged animal cell bioreactors: mechanism of cell damage and Pluronic F-68 protection. Biotechnol Prog 1990; 6(5):391-397.
70. Papoutsakis ET. Fluid-mechanical damage of animal cells in bioreactors. Trends Biotechnol 1991; 9:427-437.
71. Merchuk JC. Shear effects on suspended cells. Adv Biochem Eng=Biotechnol 1991; 44:65-95.
72. Jöbses I, Martens D, Tramper J. Lethal events during gas sparging in animal cell culture. Biotechnol Bioeng 1991; 37:484-490.
73. Zhang S, Handa-Corrigan A, Spier RE. Foaming and media surfactant effects on the cultivation of animal cells in stirred and sparged bioreactors. J Biotechnol 1992; 25(3):289-306.
74. Jordan M, Sucker H, Widmer F, Eppenberger HM. Cell-bubble interaction during aeration are strongly influenced by surfactants in the medium and can be minimized in the newly developed bubble bed reactor. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford:Butterworth- Heinemann, 1994:302-304.
75. Dey D, Emery AN. Problems in predicting cell damage from bubble bursting. Biotechnol Bioeng 1999; 65(2):240-245.
76. Chisti Y. Animal-cell damage in sparged bioreactors. Trends Biotechnol 2000; 18:320-432.
77. Papoutsakis ET. Media additives for protecting freely suspended animal cells against agitation and aeration damage. Trends Biotechnol 1991; 9:316-324.
78. Michaels JD, Nowak JE, Mallik AK, Koczo K, Wasan DT, Papoutsakis ET. Analysis of cell-to-bubble attachment in sparged bioreactors in the presence of cell-protecting additives. Biotechnol Bioeng 1995; 47:407-419.
79. Chisti Y. Animal cell culture in stirred bioreactors: observations on scale-up. Process Biochem 1993; 28:511-517.
80. Ishida M, Haga R, Nishimura N, Matuzaki HNR. High cell density suspension culture of mammalian anchorage independent cells: oxygen transfer by gas sparging and defoaming with a hydrophobic net. Cytotechnology 1990; 4:215-225.
81. Moreira JL, Cruz PE, Santana PC, Feliciano AS, Lehmann J, Carrondo MJT. Influence of power input and aeration method on mass transfer in a laboratory animal cell culture vessel. J Chem Tech Biotechnol 1995; 62:118-131.
82. Kimura R, Miller WM. Effects of elevated pCO2 and=or osmolality on the growth and recombinant tPA production of CHO cells. Biotechnol Bioeng 1996; 52:152-160.
83. deZengotita VM, Kimura R, Miller WM. Effects of CO2 and osmolality on hybridoma cells: growth, metabolism and monoclonal antibody production. Cytotechnology 1998; 28(1-3):213-227.
84. Gray DR, Chen S, Howarth W, Inlow D, Maiorella BL. CO2 in large-scale and highdensity CHO cell perfusion culture. Cytotechnology 1996; 22(1):65-78.
85. Schmelzer AE, deZengotita VM, Miller WM. Considerations for osmolality measurement under elevated pCO2: comparison of vapor pressure and freezing point osmometry. Biotechnol Bioeng 2000; 67(2):189-196.
86. Langheinrich C, Nienow AW. Control of pH in large-scale, free suspension animal cell bioreactors: alkali addition and pH excursions. Biotechnol Bioeng 1999; 66(3):171-179.
87. Qi H, Jovanoic G, Micheals J, Konstantinov K. The art and science of micro-sparging in high-density perfusion cultures of animal cells. In: Lindner-Olsson E, Lüllau E, Chatzisavido N, eds. Animal Cell Technology: From Target to Mark. Proceedings of the 17th ESACT Meeting 2001. Dordrecht: Kluwer Academic Publishers, 2002:412-415.
88. Mantanguihan R, Sajan E, Zachariou M, Olson C, Micheals J, Thrift J, Konstantinov K. Solution to the high dissolved CO2 problem in high-density perfusion culture of mammalian cells. In: Lindner-Olsson E. Lüllau E, Chatzisavido N, e. Animal Cell Technology: From Target to Market. Proceedings of the 17th ESACT Meeting 2001. Dordrecht: Kluwer Academic Publishers, 2002:412-415.
89. Miltenburger H. Züchtung von tierischen Zellen in Suspensions- und Monolayerkulturen in FermentationsgefaBe. DE 2940 446 Al, Apr 9, 1981.
90. Kuhlmann W. Optimization of a membrane oxygenation system for cell culture in stirred tank reactors. Dev Biol Stand 1987; 66:263-268.
91. Mano T, Kimura T, Iijima S, Takashiki K, Takeuchi H, Kobayashi T. Comparison of oxygen supply methods for cultures of shear-stress sensitive organisms including animal cell culture. J Chem Tech Biotechnol 1990; 47:259-271.
92. Schneider M, Reymod F, Marison IW, von Stockar U. Bubble-free oxygenation by means of hydrophobic porous membranes. Enzyme Microb Technol 1995; 17:839-847.
93. Iding K, Lütkemeyer D, Fraune E, Gerlach K, Lehmann J. Influence of alterations in culture conditions and changes in perfusion parameters on the retention performance of a 20mm spinfilter during a perfusion cultivation of a recombinant CHO cell line in pilot scale. Cytotechnology 2000; 34:141-150.
94. Ruffieux PA, von Stockar U, Marison IW. Measurement of volumetric (OUR) and determination of specific (qO2) oxygen uptake rates in animal cell cultures. J Biotechnol 1998; 63(2):85-95.
95. Ducommun P, Ruffieux P, Furter M, Marison I, von Stockar U. A new method for online measurement of the volumetric oxygen uptake rate in membrane aerated animal cell cultures. J Biotechnol 2000; 78(2):139-147.
96. Chico E, Jager V. Perfusion culture of baculovirus-infected BTI-Tn-5Bl-4 insect cells: a method to restore cell-specific-trace glycoprotein productivity at high cell density. Biotechnol Bioeng 2000; 70(5):574-586.
97. Aunins JG, Henzler HJ. Aeration in cell culture bioreactors. In: Stephanopoulos G, ed. Bioprocessing; Biotechnology. Vol. 3. VCH: Weinheim, Germany, 1993:219-281.
98. Fazekas de St, Groth S. Automated production of monclonal antibodies in a cytostat. J Immunol Methods 1983; 57:121-136.
99. Zeng AP, Deckwer WD, Hu WS. Determinants and rate laws for growth and death of hybridoma cells in continuous culture. Biotechnol Bioeng 1998; 57(6):642-654.
100. Miller WM, Blanch HW, Wilke DR. A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: Effect of nutrient concentration, dilution rate, and pH. Biotechnol Bioeng 1988; 32:947-965.
101. Miller WM, Wilke CR, Blanch HW. Transient responses of hybridoma cells to nutrient additions in continuous culture: I. Glucose pulse and step changes. Biotechnol Bioeng 1989; 33:477-486.
102. Miller WM, Wilke CR, Blanch HW. Transient responses of hybridoma cells to nutrient additions in continuous culture: II. Glutamine pulse and step changes. Biotechnol Bioeng 1989; 33:487-499.
103. Robinson DK, Widmer J, Memmert K. Effect of specific growth rates on productivity in continuous open and partial cell retention animal cell bioreactors. J Biotechnol 1992; 22(1-2):41-50.
104. Hiller GW, Clark DS, Blanch HW. Cell retention-chemostat studies of hybridoma cells-analysis of hybridoma growth and metabolism in continuous suspension culture on serum-free medium. Biotechnol Bioeng 1993; 42:185-195.
105. Figueroa C, Rice C, Mered M, Naveh D. Continuous fermentation consumption kinetics for basal media design. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:169-174.
106. Meijer JJ, Romein B, Dijken JP, Luyben KCAM. Steady-state analysis of hybridoma in chemostat culture. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology:Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:539-541.
107. Heidemann R, Lutkemeyer D, Lehmann J. Determination of Ks-values (Monod constants) for essential amino acids using CHO and hybridoma cells in batch and chemostat cultures. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:735-739.
108. Pinton H, Rabaud JN, Engasser JM, Marc A. Optimization of OKT3 hybridoma cultures in a perfusion stirred reactor. In: Spier RE, Griffiths IB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:486-488.
109. Yang JD, Angelillo Y, Chaudhry M, Goldenberg C, Goldenberg DM. Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process. Biotechnol Bioeng 2000; 69(1):74-82.
110. Tolbert WR, In: Srigley WR, Prior CP.Perfusion culture systems for large-scale pharmaceutical production. In: Spier RE, Griffiths JB, eds Animal Cell Biotechnology. Vol. 3. Orlando: Academic Press, 1988:373-393.
111. Avgerinos GC, Drapeau D, Socolow JS, Mao I, Hsiao K, Broeze RJ. Spin filter perfusion system for high density cell culture: production of recombinant urinary type plasminogen activation in CHO cells. Biotechnology 1990; 8:54-58.
112. Li S, Roder B, Wirth M. Fermentation of ATIII producing BHK cells in a double membrane perfusion bioreactor. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:445-450.
113. Jager V, Kobold A, Kohne C, Deutschmann SM, Grabenhorst E. High density insect cell culture for the production of recombinant proteins with baculovirus expression system. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:207-211.
114. Horwath BE. Facility design and validation considerations for continuous cell culture processes. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology:Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:553-559.
115. Lamotte D, Syraczek I, Marc A. Cell-settler perfusion system for the production and glycosylation of human interferon by clumped cells. In: Merten O-W, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordrecht:Kluwer Academic Publishers, 1998:395-397.
116. Bachinger T, Riese U, Eriksson R, Mandenius MF. Monitoring cellular state transitions in a production-scale CHO-cell process using an electronic nose. J Biotechnol 2000; 76(1):61-71.
117. Hiilscher M. Auslegung von Airlift-Schlaufenreaktoren fur die Kultivierung von Tierzellen im Hinblick auf Zellschddigun. Fortschrittsberichte VDI Reihe 3, VDI, 1990.
118. Esclade LRJ, Carrel S, Peringer P. Influence of the screen material on the fouling of spin filters. Biotechnol Bioeng 1991; 38:159-168.
119. Gronvik K-O, Frieberg EL, Malmstrom U. Centritech Cell -a new separation device for mammalian cells. In: Spier RE, Grififths JB, Stephenne J, Crooy PJ, eds. Advances in Animal Cell Biology and Technology for Bioprocesses. Guildford: Butterworth, 1989:428-433.
120. Hamamoto K, Ishimaru K, Tokashiki M. Perfusion culture of hybridoma cells using a centrifuge to separate cells from culture mixture. J Ferment Bioeng 1989; 67:190-194.
121. Tokashiki M, Arai T. High density culture of mouse-human hybridoma using perfusion, apparatus with multi-settling zones to separate cells from the culture medium. Cytotechnology 1989; 2:5-8.
122. Hiilscher M, Scheibler U, Onken U. Selective recycle of viable animal cells by coupling of airlift reactor and cell settler. Biotechnol Bioeng 1992; 39:442-446.
123. Trampler F, Sonderhoff SA, Pui PWS, Kilburn DG, Piret JM. Acoustic cell filter for high density perfusion culture of hybridoma cells. Biotechnology 1994; 12:281-284.
124. Velez D, Miller LO, Macmillan DJ. Use of tangential flow filtration in perfusion propagation of hybridoma cells for production of monoclonal antibodies. Biotechnol Bioeng 1989; 33:938-940.
125. Goergen JL, Marc A, Engasser JM, Rabaud JN, Pierry G, Geaugey V, Geahel I, Hache J. Development of a new membrane reactor for large scale mammalian cell culture. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:287-292.
126. Fraune E, Meichsner EFS, Kamal MN. A new spinfilter design. In: Carrondo MJT, Griffiths JB, Moreira JLP, eds. Animal Cell Technology: From Vaccine to Genetic Medicine. Dordrecht: Kluwer Academic Publishers, 1997:283-287.
127. Schiitz C, Jager V, Dreisel AJ, Wagner R. Cultivation of insect cell lines stirred membrane reactors. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:460-466.
128. Biintemeyer H, Lehmann J. Cultivation strategy and bioreactor system for optimal medium re-use and detoxification during continuous perfusion processes. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:269-275.
129. Kempken R, Biintemeyer H, Lehmann J. Long term application of medium recycling for economic antibody production. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:97.
130. Fenge C, Fraune E, Schiigerl K. Perfusion bioreactor performance at different cell bleed rates. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:264-268.
131. Himmelfarb P, Thayer PS, Martin HE. Spin filter culture: the propagation of mammalian cells in suspension. Science 1969; 164:555-557.
132. Siegel U, Fenge C, Fraune E. Spin filter for continuous perfusion of suspension cells. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:434-436.
133. Varecka R, Scheirer W. Use of a rotating wire cage for retention of animal cells in a perfusion fermentor. Dev Biol Stand 1987; 66:269-272.
134. Fenge C, Buzsaky F, Fraune E, Lindner-Olsson E. Evaluation of spin filter during perfusion culture of recombinant CHO cells. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:429-433.
135. Thayer PS. Spin filter device for suspension cultures. In: Kruse PF, Patters MK, eds. Tissue Culture: Methods and Applications. New York: Academic Press, 1973:345-351.
136. Van Wezel AL, van der Velden-de Groot CAM, Haan HH, van den Heuvel N, Schasfoort R. Large scale animal cell cultivation for production of cellular biologicals. Dev Biol Stand 1985; 60:229-236.
137. Scheirer W. High-density growth of animal cell within cell retention fermenters equipped with membranes. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 3. Orlando: Academic Press, 1988:263-281.
138. Tolbert WR, Prior CP. Perfusion culture. In: Miller AO, ed. Advanced Research on Animal Cell Technology. Dordrecht: Kluwer Academic Publishers, 1989:119-137.
139. Favre E, Peringer P, Wolden C, Kyung YS, Hu WS. Retention of animal cells in a rotating wire-cage bioreactor: a mechanistic study. In: Murakami H, ed. Trends in Animal Cell Culture Technology. Weinheim: VCH, 1990:127-132.
140. Bayeler W, Thaler T, Clements R. Some aspects of scaling-up animal cell processes. In: Murakami H, ed. Trends in Animal Cell Culture Technology. Weinheim: VCH:1990:225-233.
141. Hu WS, Scholz MT, Favre E, Seamans TC. A new look at animal cell bioreactor development. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:370-380.
142. Sumeghy Z. Improved cell retention system based on the rotating sieve technique. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:437-447.
143. Yabannavar VM, Singh V, Connelly NV. Mammalian cell retention in a spinfilter perfusion bioreactor. Biotechnol Bioeng 1992; 40:925-933.
144. Favre E, Thaler T. An engineering analysis of rotating sieves for hybridoma cellretention in stirred tank bioreactors. Cytotechnology 1992; 9:11-19.
145. Deo YM, Mahadevan MD, Fuchs R. Practical considerations in operation and scale-up of spin-filter based bioreactors for monoclonal antibody production. Biotechnol Prog 1996; 12:57-64.
146. Trocha M, von Rohr R, Stimeghy Z. Contribution to the understanding of retention of animal cells in spinfilters. In: Carrondo MJT, Griffiths IB, Moreira JLP, eds. Animal Cell Technology: From Vaccine to Genetic Medicine. Dordrecht: Kluwer Academic Publishers, 1997:405-409.
147. Jem KJ, Fateen S, Michaels J. Mixing phenomena in industrial bioreactors with perfusion spin filters. In: Spier RE, Griffiths IB, Berthold W, eds. Animal Cell Technology:Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:392-396.
148. Phiss R, Doyen D, van der Pol L, Romette J.-L. Progress in animal cell perfusion technology with superspin. In: Spier RE, Griffiths IB, Berthold W, eds. Animal Cell Tech- nology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:218-221.
149. Jan DCH, Emery AN, Al-Rubeai M. Optimization of spin-filter performance in the intensive culture of suspended cells. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:448-451.
150. Kitano K, Shintani Y, Ichimori Y, Tsukamoto K, Sasai S, Kida M. Production of human monoclonal antibodies by heterohybridomas. Appl Microbiol Biotechnol 1986; 24:282-286.
151. Takazawa Y, Tokashiki M, Hamamoto K, Murakami H. High cell density perfusion of hybridoma cells recycling high molecular weight components. Cytotechnology 1988; 1:171-178.
152. Bart BC, Davis RH, Kompala DS. Inclined sedimentation for selective retention of viable hybridomas in a continuous suspension bioreactor. Biotechnol Prog 1990; 6:458-464.
153. Knaack C, Andre G, Chavarie C. Conical bioreactor with internal lamella settler for perfusion culture of suspension cells. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:230-233.
154. Tokashiki M, Arai T. High density culture of hybridoma cells using a perfusion culture apparatus with multi-settling zones. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:467-469.
155. Sato S, Kawamura K, Fuyiyoshi N. Animal cell cultivation for production of biological substances with a novel perfusion culture apparatus. J Tissue Culture Methods 1983; 8(4):167-171.
156. Hosoi S, Miyaji H, Satoh M, Kurimoto T, Mihara A, Fujiyoshi N, Itoh S, Sato S. Optimization of cell culture conditions for production of biologically active proteins. Cytotechnology 1991; 5:17-34.
157. Tokashiki M, Yokoyama S. Bioreactors designed for animal cells. In: Hauser HJ, Wagner R, eds. Mammalian Cell Biotechnology in Protein Production. de Gruyter, 1997:279-317.
158. Searles JA, Todd P, Kompala DS. Perfusion culture of suspended CHO cells employing inclined sedimentation. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology:Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:240-242.
159. Bjorling T, Malmstrom U. Bleeding out dead cells from fermentation systems. Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:394-399.
160. Gaida Th, Doblhoff O, Strutzenberger K, Katinger HBW, Groschl B, Benes E. Scaleup of ultrasonic resonance field cell separation devices used in cell technology. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:163-175.
161. Woodside SM, Bowen BD, Piret JM. Mammalian cell retention devices for stirred perfusion bioreactors. Cytotechnology 1998; 28:163-175.
162. Birch JR, Arathoon R. Suspension culture of mammalian cells. Bioprocess Technol 1990; 10:251-270.
163. Chisti MY, Moo-Young M. Airlift reactors: characteristics, applications and design considerations. Chem Eng Commun 1987; 60:195-242.
164. Rhodes M, Birch J. Large scale production of proteins from mammalian cells. Biotechnology 1988; 6:518-523.
165. Konopitzky K, Kanzler O, Winhab K. Monoclonal antibody production using an airlift fermenter system consisting of a continuous seed fermenter and a fed batch production fermenter. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:467-469.
166. Boraston SJFRC, Marshall CM, Gardiner SAM. The effect of high gas sparge rates in airlift fermenter culture on hybridoma cell growth and antibody production in low protein medium. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology:Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:167-171.
167. Tramper J, Smit D, Straatman J, Vlak JM. Bubble-column design for growth of fragile insect cells. Bioprocess Eng 1988; 3:37-41.
168. Martens DE, Nollen EAA, Hardeveld M, Groot CAMV, Gooijer CD, Beuvery EC, Tramper J. Death rate in a small air-lift loop reactor of Vero cells grown on solid microcarrier and in macroporous microcarriers. Cytotechnology 1997; 23(1-3):61-75.
169. Grima EM, Chisti Y, Mooyoung M. Characterization of shear rates in airliftbioreactors for animal cell culture. J Biotechnol 1997; 54(3):195-210.
170. Merchuk JC. Why use air-lift bioreactors? Trends Biotechnol 1990; 8:66-71.
171. Bliem R, Konopitzky K, Katinger H. Industrial animal cell reactor systems: aspects of selection and evaluation. In: Fiechter A, ed. Advances in Biochemical Engineering= Biotechnology. Vol. 44. Berlin Springer, 1991:1-25.
172. Handa A, Emery AN, Spier R. On the evaluation of gas-liquid interfacial effects on hybridoma viability in bubble column bioreactors. Dev Biol Stand 1989; 66:241-252.
173. Handa-Corrigan A, Emery AN, Spier RE. Effect of gas-liquid interfaces on the growth of suspended mammalian cells: mechanisms of cell damage by bubbles. Enzyme Microb Technol 1989; 11:230-235.
174. Huelscher M, Onken U. Mechanical damage of suspended animal cells in directly sparged bioreactors. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology:Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:448-451.
175. Su WW. Bioreactors, perfusion. In: Spier RE, ed. Encyclopedia of Cell Technology. Vol. 1. New York: Wiley, 2000:230-242.
176. Lu GZ, Thompson BG, Suresh MR, Gray MR. Cultivation of hybridoma cells in an inclined bioreactor. Biotechnol Bioeng 1995; 45:176-186.
177. Sucker HG, Jordan M, Eppenberger HM, Wimer F. Bubble bed reactor: a reactordesign to minimize the damage of bubble aeration on animal cells. Biotechnol Bioeng 1994; 44:1246-1254.
178. Knazek RA, Gullino PM, Kohler PO, Dedrick RL. Cell culture in artificial capillaries:an approach to tissue growth in vitro. Science 1972; 178:65-67.
179. Labecki M, Bowden B, Piret J. Two-dimensional analysis of protein transport in the extracapillary space of hollow-fibre bioreactors. Chem Eng Sci 1996; 51(17):4197-4213.
180. Dowd JE, Weber I, Rodriguez B, Piret JM, Kwok KE. Predictive control of hollowfiber bioreactors for the production of monoclonal antibodies. Biotechnol Bioeng 1999; 63(4):484-492.
181. Nagel A, Effenberger E, Koch S, Liibbe L, Marx U. Human cancer and primary cell culture in the new hybrid bioreactor system Technomouse. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:296-301.
182. Gramer MJ, Poesch DM, Conroy MJ, Hammer BE. Effect of harvesting protocol on performance of a hollow fiber bioreactor. Biotechnol Bioeng 1999; 65(3):334-340.
183. Cima LG, Blanch HW, Wilke CR. A theoretical and experimental evaluation of a novel radial-flow hollow fiber reactor for mammalian cell culture. Bioprocess Eng 1990; 5:19-30.
184. Altshuler GL, Sowek JA, Belfort G. IgG production in microporous hollow fiberbioreactors. In: Neijssel OM, van der Meer RR, Luyben KChAM, eds. Proceedings of the 4th European Congress on Biotechnology. Amsterdam: Elsevier Science Publishers, 1987:127-129.
185. Heath C, Dilwith R, Belfort G. Methods for increasing monoclonal antibody production in suspension and entrapped cell cultures: biochemical and flow cytometric analysis as a function of medium serum content. J Biotechnol 1990; 15:71-90.
186. Dhainaut F, Meterreau JL, Mas MP, Potentini C, Mignot G. Scale-up of human IgGl production by a lymphoblastoid cell line in hollow fiber system. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:502.
187. Goffe RA, Shi JY, Nguyen AKC. Medium additives for high performance cell culture in hollow fiber bioreactors. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:527-529.
188. Kidwell WR. Filtering out inhibition. Biotechnology 1989; 7.
189. Tharakan JP, Gallagher SL, Chau PC. Hollow-fiber bioreactors for mammalian cell culture. Adv Biotechnol Processes 1988; 7:153-184.
190. Piret JM, Cooney CL. Immobilized mammalian cell cultivation in hollow fiber bioreactors. Biotechnol Adv 1990; 8:763-783.
191. Brotherton JD, Chau PC. Modeling of axial-flow hollow fiber cell culture bioreactors. Biotechnol Prog 1996; 12(5):575-590.
192. Uludag H, De Vos P, Tresco PA. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev 2000; 42(1-2):29-64.
193. Tharakan JP, Chau PC. Operation and pressure distribution of immobilized cell hollow fiber bioreactors. Biotechnol Bioeng 1986; 28:1064-1071.
194. Piret JM, Cooney CL. Mammalian cell and protein distributions in ultrafiltration hollow fiber bioreactors. Biotechnol Bioeng 1990; 36:902-910.
195. Taylor DG, Piret JM, Bowen BD. Protein polarization in isotropic membrane hollow fiber bioreactors. AIChE J 1994; 40:321-333.
196. Hirschel MD, Gruenberg MX. An automated hollow fiber system for the large scale manufacture of mammalian cell secreted product. In: Lydersen BK, ed. Large Scale Cell Culture Technology. London: Macmillan, 1987:115-144.
197. Shi Y, Sardonini CA, Goffe RA. The use of oxygen carriers for increasing the production of monoclonal antibodies from hollow fibre bioreactors. Res Immunol 1998; 149(6):576-587.
198. Brotherton JD, Chau PC. Modeling analysis of an intercalated-spiral alternate-deadended hollow fiber bioreactor for mammalian cell cultures. Biotechnol Bioeng 1990; 35:375-394.
199. Ku K, Kuo MJ, Delente J, Wildi BS, Feder J. Development of a hollow-fiber system for large-scale culture of mammalian cell’s. Biotechnol Bioeng 1981; 23:79-95.
200. Tyo MA, Bubulian BJ, Menken BZ, Murphy T. Large-scale mammalian cell culture utilizing Acusyst technology. In: Spier RE, Griffiths IB, eds. Animal Cell Biotechnology. Vol. 3. Orlando: Academic Press, 1988:357-371.
201. Heath C, Belford G. Immobilization of suspended mammalian cells: analysis of hollow fiber and microcapsule bioreactors. Adv Biochem Eng=Biotechnol 1987; 34:1-31.
202. Marx U, Tanzmann H, Jaeger V, Kiessig ST, von Baehr R. Simultaneous cultivation of two hybridoma cell lines in a hollow fiber bioreactor. In: Spier RE, Griffiths JB, Mac-Donald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford:Butterworth-Heinemann, 1992:534-537.
203. Cytogen: http:==www.cytogen.com=prosta_mstr.html.
204. ProstaScint: http:==www.fda.gov=cber=products=capcytl0289 6.htm.
205. Lamers CHJ, Griend RJ, Gratama JW, Bolhuis RLH. Activation and expansion of human cytotoxic T lymphocytes in hollow fiber bioreactors. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:735-737.
206. Adamson SR, Fitzpatrick SL, Behie LA, Gaucher GM, Lesser BH. In vitro production of high titre monoclonal antibody by hybridoma cells in dialysis culture. Biotechnol Lett 1983; 5(9):573-578.
207. Hagedorn J, Kargi F. Coiled tube membrane bioreactor for cultivation of hybridomacells producing monoclonal antibodies. Enzyme Microb Technol 1990; 12:824-829.
208. Kleuser B, Kocher HP, Mernmert K, Stenz M, Straubhaar B, Zurini M. Configuration of a simple dialysis membrane bioreactor suitable for large-scale application. In: Bernard A, Griffiths B, Noe W, Wurm F, eds. Animal Cell Technology: Products from Cells, Cells as Products. Dordrecht: Kluwer Academic Publishers, 1999:187-191.
209. Comer MJ, Kearms MJ, Wahl I, Muster M, Lorenz T, Szperalski B, Koch S, Behrendt U, Brunner H. Industrial production of monoclonal antibodies and therapeutic proteins by dialysis fermentation. Cytotechnology 1990; 3:295-299.
210. Markl H, Lechner M, Gotz F. A new dialysis fermenter for the production of high concentrations of extracellular enzymes. J Ferment Bioeng 1990; 69:244-249.
211. Portner R, Markl H. Dialysis cultures. Appl Microbiol Biotechnol 1998; 50:403-414.
212. Tolbert WR, White PJ, Feder J. Perfusion culture systems for production of mammalian cell biomolecules. In: Feder J, Tolbert WR, eds. Large-scale Mammalian Cell Culture. Orlando: Academic Press, 1985:1-18.
213. Klement G, Scheirer W, Katinger HWD. Construction of a large scale membrane reactor system with different compartments for cells, medium and product. Dev Biol Stand 1985; 66:221-226.
214. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210(21):908-910.
215. Rupp RG. Use of cellular microencapsulation in large-scale production of monoclonalantibodies. In: Feder J, Tolbert WR, eds. Large-Scale Mammalian Cell Culture. Orlando: Academic Press, 1985:19-38.
216. Duff RG. Microencapsulation technology: a novel method for monoclonal antibody production. Trends Biotechnol 1985; 3:167-170.
217. Lee GM, Palsson BO. Immobilization can improve the stability of hybridoma antibody productivity in serum-free media. Biotechnol Bioeng 1990; 36:1049-1055.
218. Nilsson K, Scheirer W, Katinger HWD, Mosbach K. Production of monoclonal antibodies by agarose-entrapped hybridoma cells. Methods Enzymol 1986; 121:352-361.
219. Merten OW, Dautzenberg H, Palfi GE. A new method for the encapsulation of mammalian cells. Cytotechnology 1991; 7:121-130.
220. Shen BQ, Greenfield PF, Reid S. Hybridoma cells in a protein-free medium within a composite gel perfusion bioreactor. Cytotechnology 1994; 16(1):51-58.
221. Seifert DB, Phillips JA. Porous alginate-poly (ethylene glycol) entrapment system for the cultivation of mammalian cells. Biotechnol Prog 1997; 13(5):569-576.
222. Ray NG, Vournakis JN, Runstadler PW, Tung AS, Venkatasubramanian K. Physiology of hybridoma and recombinant Chinese hamster ovary cells immobilized in collagen matrix. In: De Bont JM, Visser J, Mattiasson B, Tramper J, eds. Physiology of Immobilized Cells. Amsterdam: Elsevier, 1990:18.
223. Nilsson K. Methods for immobilizing animal cells. Trends Biotechnol 1987; 5:73-78.
224. Vogelsang C, Wijffels RH, Ostgaard K. Rheological properties and mechanical stability of new gel-entrapment systems applied in bioreactors. Biotechnol Bioeng 2000; 70(3):247-253.
225. King GA, Kaugulis AJ, Faulkner P, Goosen MFA. Alginate-polylysine microcapsules of controlled membrane molecular weight cutoff for mammalian cell culture engineering. Biotechnol Prog 1987; 3:231-340.
226. Lu MZ, Lan HL, Wang FF, Chang SJ, Wang YJ. Cell encapsulation with alginate and - phenoxycinnamylidene-acetylatedpoly(allylamine). Biotechnol Bioeng 2000; 70(5):479-483.
227. Serp D, Cantana E, Heinzen C, Stockar UV, Marison IW. Characterization of an encapsulation device for the production of monodisperse alginate beads for cell immobilization. Biotechnol Bioeng 2000; 70(1):41-53.
228. Martinson A, Storro L, Skjak-Braek G. Alginate as immobilization material: III. Diffusional properties. Biotechnol Bioeng 1992; 39:186-194.
229. Lee GM, Kim SJ, Palsson BO. Enhanced specific antibody productivity of calcium alginate- entrapped hybridoma is cell line-specific. Cytotechnology 1994; 16(1):1-15.
230. Lee GM, Chuck AS, Palsson BO. Cell culture conditions determine the enhancement of specific monoclonal antibody productivity of calcium alginate-entrapped S3H5=Y2aA2 hybridoma cells. Biotechnol Bioeng 1993; 41:330-340.
231. Kwong C-W, Hsieh J-H, Syu M-L, Chou S.-S. Anti-hepatitis B surface antigenmonoclonal antibody IgM production in suspension and immobilized cell bioreactors. Biotechnol Lett 1989; II(6):377-382.
232. Tai IT, Sun AM. Microencapsulation of recombinant cells: a new delivery system for gene therapy. FASEB J 1993; 7(11):1061-1069.
233. Basic D, Vacek I, Sun AM. Microencapsulation and transplantation of genetically engineered cells: a new approach to somatic gene therapy. Artificial Cells, Blood Substitutes, & Immobilization Biotechnology 1996; 24(3):219-255.
234. Chang PL, Van Raamsdonk JM, Hortelano G, Barsoum SC, MacDonald NC, Stockley TL. The in vivo delivery of heterologous proteins by microencapsulated recombinant cells. Trends Biotechnol 1999; 17(2):78-83.
235. Freshney IR. Culture of Animal Cells: A Manual of Basic Techniques. New York:Willey-Liss, 1994.
236. Jensen MD. Production of anchorage-dependent cells-problems and their possible solutions. Biotechnol Bioeng 1981; XXIII:2703-2716.
237. Archer R, Wood L. Production tissue culture by robots. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Processes and Products. Oxford: Butterworth-Heinemann, 1992:85.
238. Aunins JG, Bibila TA, Gatchalian S, Hunt GR, Junker BH, Lewis JA, Seifert DB, Licari P, Ramasubramanyan K, Ranucci CS, Seamans TC, Zhou W, Waterbury W, Buckland BC. Reactor development for the hepatitis a vaccine VAQTA. In: Carrondo MJT, Griffiths B, Moreira JLP, eds. Animal Cell Technology: From Vaccine to Genetic Medicine. Dordrecht: Kluwer Academic Publishers, 1997:88.
239. Beeksma LA, Kompier R. Cell growth and virus propagation in the Costar Cellcube system. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology:Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:98.
240. Van Wezel AL. Growth of cell-strains and primary cells on micro-carriers in homogeneous culture. Nature 1967; 216:64-66.
241. Lundgren B, Bluml G. Microcarriers in cell culture production. In: Subramanian G, ed. Bioseparation and Bioprocessing. Vol. 2. Weinheim: Wiley-VCH, 1998:165-222.
242. Looby D, Griffiths B. Immobilization of animal cells in porous carrier culture. Trends Biotechnol 1990; 8:204-209.
243. Berg GJ, Bodeker BGD. Employing a ceramic matrix for the immobilization of mammalian cells in culture. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 3. Orlando: Academic Press, 1988:321-335.
244. Groot CAMV. Microcarrier technology, present status and perspective. Cytotechnology 1995; 18:51-56.
245. Butler M. A comparative review of microcarriers available for growth of anchoragedependent animal cells. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 3. Orlando: Academic Press, 1988:3:283-303.
246. Gatot C, Trampler F, Wanderpepen M-P, Harfield J, Oudshoorn A, Johansson A, Nielsen V, Miller AOA. Use of a new microcarrier with two-dimensional geometry for the culture of anchorage-dependent cells in sonoperfused, continuously stirred tank bior- eactors. In: Merten O-W, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordrecht: Kluwer Academic Publishers, 1998:377-380.
247. Groot CAMV. Microcarrier technology, present status and perspective. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:899-905.
248. Kong D, Gentz R, Zhang J. Cell growth and protein formation on various microcarriers. Cytotechnology 1999; 29(2):151-158.
249. Nilsson K, Buzsaky F, Mosbach K. Growth of anchorage dependent cells on macroporous microcarrier. Biotechnology 1986; 4:989-990.
250. Almgren J, Nilsson C, Petersson AC, Nilsson K. Cultispher-macroporous gelatin microcarrier-new applications. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:434-438.
251. Looby D, Racher AJ, Fuller JP, Griffiths B. Evaluation of porous silicone carrier (Immobasil G) for animal cell culture. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht:Kluwer Academic Publishers, 1995:783-786.
252. Nomura N, Matsumura M, Kataoka H, Saijo K, Ohno T. Production of human growth hormone by protein-free cultivation of anchorage-dependent cells with porous cellulose carrier. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology:Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:817-821.
253. Long RJ. The production and regulation of veterinary virus vaccines. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Orlando: Academic Press, 1994; 6:281-313.
254. Chun BH, Woo GJ, Cheung HS, Moon HM. Production of live attenuated varicellazoster virus in human embryonic lung cells microcarrier. In: Carrondo MJT, Griffiths JB, Moreira JLP, eds. Animal Cell Technology: From Vaccine to Genetic Medicine. Dordrecht: Kluwer Academic Publishers, 1997:185-189.
255. Looby D, Tree J, Talukder A, Hayes K, House H, Stacey G. The production of influenza virus by immobilised MDCK cells. In: Merten O-W, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordrecht:Kluwer Academic Publishers, 1998:551-554.
256. Berry JM, Barnabe N, Coombs KM, Butler M. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers. Biotechnol Bioeng 1999; 62(1):12-19.
257. Moran E. A microcarrier-based cell culture process for the production of a bovine respiratory syncytial virus vaccine. Cytotechnology 1999; 29(2):135-149.
258. Merten OW, Kallel H, Manuguerra JC, Tardy-Panit M, Crainic R, Delpeyroux F, Werf SV, Parrin P. The new medium MDSS2N, free any animal protein supports cell growth and production of various viruses. Cytotechnology 1999; 30(1-3):191-201.
259. Montagnon B, Vincent-Falquet JC, Fanget B. Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine; promising results. Dev Biol Stand 1984; 55:37-42.
260. Griffiths B. Animal cells-the breakthrough to a dominant technology. Cytotechnology 1990; 3:109-116.
261. Smiley AL, Hu W-S, Wang DIC. Production of human immune interferon by recombinant mammalian cells cultivated on microcarriers. Biotechnol Bioeng 1989; 33:1182-1190.
262. Kamiya K, Yanagida K, Shirokaze J. Subculture method for large scale cell culture using macroporous microcarrier. In: Beuvery EC, Griffiths IB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:759-763.
263. Wang Y, Ouyang F. Bead-to-bead transfer of Vero cells in microcarrier culture. Cytotechnology 1999; 31(3):221-224.
264. Miithing J, Duvar S, Nerger S, Biintemeyer H, Lehmann J. Microcarrier cultivation of bovine aortic endothelial cells in spinner vessels and a membrane stirred bioreactor. Cytotechnology 1995; 18(3):193-206.
265. Fenge C, Jansson L, Froberg T, Danielsson A, Jonsson M, Sygowski L, Moore C, Snyder D, Liillau E, Wood M. Process development for functional membrane receptor production in mammalian cells. In: Lindner-Olsson E, Liillau E, Chatzisavido N, eds. Animal Cell Technology: From Target to Mark. Proceedings of the 17th ESACT Meeting 2001. Dordrecht: Kluwer Academic Publishers, 2002:441-445.
266. Glacken MW, Fleischaker RJ, Sinskey AJ. Reduction of waste product excretion via nutrient control: possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells. Biotechnol Bioeng 1986; 28:1376-1389.
267. Butler M, Imamura T, Thomas J, Thilly WG. High yields from microcarrier cultures by medium diffusion. J Cell Sci 1983; 61:351-363.
268. Croughan MS, Wang DIC. Growth and death in overagitated microcarrier cell culture. Biotechnol Bioeng 1989; 33:731-744.
269. Alves PM, Moreira JL, Rodrigues JM, Aunins JG, Carrondo MJT. Two-dimensional versus three-dimensional culture systems: effects on growth and productivity of BHK cells. Biotechnol Bioeng 1996; 52(3):429-432.
270. Ng YC, Berry JM, Butler M. Optimization of physical parameters for cell attachment and growth on macroporous microcarriers. Biotechnol Bioeng 1996; 50(6):627-635.
271. Croughan MS, Hamel JF, Wang DIC. Hydrodynamic effects on animal cells grown in microcarrier cultures. Biotechnol Bioeng 2000; 67(6):841-852.
272. Gregoriades N, Clay J, Ma N, Koelling K, Chalmers JJ. Cell damage of microcarrier cultures as a function of local energy dissipation created by a rapid extensional flow. Biotechnol Bioeng 2000; 69(2):171-182.
273. Bauer P, Hancock L, Rathman J, Chalmers JJ. Cell-microcarrier adhesion to gas-liquid interfaces and foam. Biotechnol Prog 2000; 16(1):125-132.
274. Dean RC Jr, Karkare SB, Ray NG, Runstadler PW Jr, Venkatasubramanian K. Largescale culture of hybridoma and mammalian cells in fluidized bed bioreactors. Ann NY Acad Sci 1987; 506:129-146.
275. Runstadler PW, Cernek SR. Large-scale fluidized-bed, immobilized cultivation of animal cells at high densities. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 3. Orlando: Academic Press, 1988:305-320.
276. Vournakis JN, Runstadler PW. Optimization of the microenvironment for mammalian cell culture in flexible collagen microspheres in a fluidized-bed bioreactor. In: Ho CH, Wang DIC, eds. Animal Cell Bioreactors. Oxford: Butterworth, 1991:305-326.
277. Paul EDL. Design and scale-up of an anchorage-dependent mammalian cell bioreactor. Ann NY Acad Sci 1988;642-649.
278. Ray NG, Tung AS, Hayman EG, Vournakis JN, Runstadler PWJ. Continuous cell cultures in fluidized-bed bioreactors. Cultivation of hybridomas and recombmant Chinese hamster ovary cells immobilized in collagen microspheres. Ann NY Acad Sci 1990; 589:443-457.
279. Ray NG, Tung AS, Runstadler PW, Vournakis IN. Enhanced productivity of hybridoma and recombinant CHO cell cultures by Pluronic F-68 and other medium components, and by increased perfusion rates, in fluidized-bed bioreactors. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:502-511.
280. Looby D, Griffiths JB. Immobilisation of animal cells in fixed and fluidized porous glass sphere reactors. In: Spier RE, Griffiths JB, Stephenne J, Crooy PJ, eds. Advances in Animal Cell Biology and Technology for Bioprocesses. Guildford: Butterworths, 1989:336-344.
281. Kratje R, Jager V, Wagner R. Comparison of the production efficiency of mammalian cells grown in a fluidized bed and in a stirred tank reactor. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:528-532.
282. Kratje R, Jager V, Wagner R. Evaluation of the production of recombinant human interleukin-2 in a fluidized bed bioreactor. Biotechnol Bioeng 1992; 39:233-242.
283. Ltillau E, Biselli M, Wandrey C. Growth and metabolism of CHO-cells in porous glass carriers. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:252-255.
284. Noll TBM, Wandrey C. On-line biomass monitoring of immobilised hybridoma cells by dielectrical measurements. In: Carrondo MJT, Griffiths JB, Moreira JLP, eds. Animal Cell Technology: from Vaccine to Genetic Medicine. Dordrecht: Kluwer Academic Publishers, 1997:289-294.
285. Hambach B, Biselli M, Runstadler PW, Wandrey C. Development of a reactor-integrated aeration system for cultivation of animal cells in fluidized beds. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:381-385.
286. Born C, Biselli M, Wandrey C. Production of monoclonal antibodies in a pilot scale fluidized bed bioreactor. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:683-686.
287. Biselli M, Born C, Schroder B, Wandrey C. Gasification-tube module and reactor for cell cultivati. US 5, 601, 757, February 11, 1997.
288. Papaspyrou, M. Personal communication. 2001 June.
289. Reiter M, Bluml G, Gaida T, Zach N, Unterluggauer F, Doblhoff-Dier O, Noe M, Plail R, Huss S, Katinger H. Modular integrated fluidized bed bioreactor technology. Biotechnology 1991; 9(11):1100-1102.
290. Reiter M, Zach N, Gaida T, Bluml G, Doblhhoff-Dier O, Unterluggauer F, Katinger H. Oxygenation in fluidized bed bioreactors using the microsparging technique. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:386-392.
291. Bluml G. Entwicklung und Etablierung eines macroporosen Carrier aus Polyethylen zur Immobilisierung von (tierischen) Zellen. Ph.D. Thesis. Instituted for Applied Microbiology, University of Agriculture, Vienna, Austria, 1994.
292. Bluml G, Reiter M, Zach N, Gaida T, Schmatz C. Development of a new type of macroporous carrier. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology:Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:501-504.
293. Ducommun P, Bolzonella I, Rhiel M, Pugeaud P, von Stockar U, Marison IW. On-line determination of animal cell concentration. Biotechnol Bioeng 2001; 72(5):515-522.
294. Earle RW, Evans VJ, Schilling EX. Extension of cellophane substrate procedure to growth of in vitro cultures of large areas. J Natl Cancer Inst 1950; 10:943-967.
295. Earle WR, Evans VJ, Stanford KK, Shannon JE, Waltz HK. Influence of glass and cellophane substrates on proliferation of strain L cells in tissue culture. J Natl Cancer Inst 1951; 12:563-567.
296. Earle WR, Schilling EL, Shannon JE. Growth of animal tissue cells on three dimensional substrates. J Natl Cancer Inst 1951; 12:179-193.
297. Spier RE, Whiteside JP. The production of foot-and-mouth disease virus from BHK 21 C13 cells grown on the surface of glass spheres. Biotechnol Bioeng 1976l; 18:649-657.
298. Whiteside JP, Whiting B, Spier RE. Development of a methodology for the production of FMD virus from BHK 21 Vol. 3. C13 monolayer cells grown in a 100-L glass sphere propagator. Dev Biol Stand 1979; 42:113-119.
299. Burbidge C. The mass culture of human diploid fibroblast in packed beds of glass beads. Dev Biol Stand 1980; 46:169-172.
300. Griffiths JB, Thornton B, McEntee I. The development and use of microcarriers and glass sphere culture techniques for the production of herpes simplex virus. Dev Biol Stand 1982; 50:103-110.
301. Brown PC, Figueroa C, Costello MAC, Oakley R, Maciukas SM. Protein production from mammalian cells grown on glass beads. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 3. Orlando: Academic Press, 1988:251-262.
302. Looby D, Griffiths JB. Fixed bed porous glass sphere (Porosphere) bioreactors for animal cell culture. Cytotechnology 1988; 1:339-346.
303. Bohmann A, Portner R, Schmieding J, Kasche V, Markl H. The membrane dialysis bioreactor with integrated radial-flow fixed bed - a new approach for continuous cultivation of animal cells. Cytotechnology 1992; 9(1-3):51-57.
304. Lazar A, Reuveny S, Muzrahi M, Avtalion M, Whiteside JP, Spier RE. Production of biologicals by animal cells immobilized in polyurethan foam matrix. In: Spier RE, Griffiths JB, eds. Modern Approaches to Animal Cell Technology. Oxford: Butterworth, 1987:437-448.
305. Looby D, Racher A, Griffiths JB, Dowsett AB. The immobilisation of animal cells in fixed and fluidized porous sphere reactors. In: De Bont JAM, Visser J, Mattiasson B, Tramper J, eds. Physiology of Immobilised Cells. Amsterdam: Elsevier Science Publishers, 1990:255-246.
306. Racher AJ, Looby D, Griffiths JB. Use of lactate dehydrogenase release to assess changes in culture viability. Cytotechnology 1990; 3(3):301-307.
307. Kompier R, Kislev N, Segal I, Kadouri A. Use of a stationary bed reactor and serumfree medium for the production of recombinant proteins in insect cells. Enzyme Microb Technol 1991; 13:822-827.
308. Wang G, Zhang W, Freedman D, Eppstein L, Kadouri A. Continuous production of monoclonal antibodies in Celligen packed bed reactor using Fibra-Cel carrier. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:460-464.
309. Kadouri A. Cultivation of anchorage-dependent mammalian cells and production of various metabolites. Colloids Surfaces B: Biointerfaces 1994; 2:265-272.
310. Kang SH, Kim BG, Lee GM. Justification of continuous packed-bed reactor for retroviral vector production from amphotropic 0CRIP murine producer cell. Cytotechnology 2000; 34(1-2):151-158.
311. Wang G, Zhang W, Jacklin C, Freedman D, Eppstein L, Kadouri A. Modified Celli-Gen-packed bed bioreactors for hybridoma cell cultures. Cytotechnology 1992; 9:41-49.
312. Kaufman JB, Wang G, Zhang W, Valle MA, Shiloach J. Continuous production and recovery of recombinant Ca2þ binding receptor from HEK 293 cells using perfusion through a packed bed bioreactor. Cytotechnology 2000; 33(1):3-11.
313. Gumtisderelioglu M, Aslankaraoglu E, Giirhan SI. Rabies virus production in nonwoven polyester fabric (NWPF) packed-bed reactors. Biotechnol Appl Biochem 2001; 33:167-172.
314. Yanagi K, Miyoshi H, Fukuda H, Ohshima N. A packed-bed reactor utilizing porous resin enables high density culture of hepatocytes. Appl Microbiol Biotechnol 1992; 37:316-320.
315. Miyoshi H, Yanagi K, Fukuda H, Ohshima N. Long-term performance of albumin secretion of hepatocytes cultures in a packed-bed reactor utilising porous resin. Artificial Organs 1996; 20(7):803-807.
316. Meissner P, Werner P, Schronder B, Herfurth C, Wandrey C, Biselli M. Expansion of human hematopoietic progenitor cells in a fixed bed bioreactor. In: Merten O-W, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordrecht: Kluwer Academic Publishers, 1998:635-636.
317. Ghanem A, Shuler ML. Characterization of a perfusion reactor utilizing mammalian cells on microcarrier beads. Biotechnol Prog 2000; 16(3):471-479.
318. Lydersen BK, Pugh GG, Paris MS, Sharma BP, Noll LA. Ceramic matrix for large scale animal cell culture. Biotechnology 1985; 3:63-67.
319. Bodeker BGD, Hewlett G, Nerger D, Schlumberger HD. Verfahren und Vorrichtung zur Kultivierung immobilisierter oder adharierter Saugerzellen sowie dessen Verwendung bei der Herstellung von Protein. EP 0270905, June 15, 1988.
320. Bodeker BGD, Hiibner GE, Hewlett G, Schlumberger HD. Production of human monoclonal antibodies from immobilized cells in the Opticell culture system. Dev Biol Stand 1987; 66:473-479.
321. Werner RG, Merk W, Walz F. Fermentation with immobilized cell cultures. Arzneimittelforschung 1988; 38(2):320-325.
322. Lechner M, Markl H, Gotz F. Lipase production of Streptococcus carnosus in a dialysis fermentor. Appl Microbiol Biotechnol 1988; 28:345-349.
323. Kurosawa H, Markl H, Niebuhr-Redder C, Matsumura M. Dialysis bioreactor with radial-flow fixed bed for animal cell culture. J Ferment Bioeng 1991; 72(1):41-45.
324. Bohmann A, Portner R, Markl H. Performance of a membrane dialysis bioreactor with a radical-flow fixed bed for the cultivation of a hybridoma cell line. Appl Microbiol Biotechnol 1995; 43:772-780.
325. Chiou TW, Murakami S, Wang DIC, Wu WT. A fiber bed bioreactor for anchorage dependent animal cell culture: Part 1. Bioreactor design and operations. Biotechnol Bioeng 1991; 37:756-761.
326. Junker BH, Chiou T, Wang DIC, Buckland BC. Cultivation of virus antigen in fibroblast cells using a glass fiber bed reactor. Biotechnol Bioeng 1993; 42:635-642.
327. Highfill JG, Haley SD, Kompala DS. Large-scale production of murine bone marrow cells in an airlift packed bed bioreactor. Biotechnol Bioeng 1996; 50(5):514-520.
328. Junker BH, Seamans TC, Ramasubramanyan K, Aunins J, Paul E, Buckland BC. Cultivation of attenuated hepatitis A virus antigen in a titanium static mixer reactor. Biotechnol Bioeng 1994; 44:1315-1324.
329. Glacken MW, Adema E, Sinskey AJ. Mathematical descriptions of hybridoma culture kinetics: I. initial metabolic rates. Biotechnol Bioeng 1988; 32:491-506.
330. Lee YK, Yap PK, Teoh AP. Correlation between steady-state cell concentration and cell death of hybridoma cultures in chemostat. Biotechnol Bioeng 1995; 45:18-26.
331. Biintemeyer H, Siwiofa S, Lehmann J. Inhibitors of cell growth: accumulation and concentration. In: Carrondo MJT, Griffiths JB, Moreira JLP, eds. Animal Cell Technology:From Vaccine to Genetic Medicine. Dordrecht: Kluwer Academic Publishers, 1997:651-655.
332. Goergen J-L, Marc A, Engasser J.-M. Kinetics and simulation of animal cell processes. In: Hauser HJ, Wagner R, eds. Mammalian Cell Biotechnology in Protein Production. de Gruyter, 1997:345-371.
333. Jo E-C, Kim D-L, Moon HM. Step-fortifications of nutrients in mammalian cell culture. Biotechnol Bioeng 1993; 42:1218-1228.
334. Xie L, Wang DIC. Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies. Biotechnol Bioeng 1994; 43:1175-1189.
335. Merten O-W, Keller H, Cabanie L, Leno M, Hardefelt M. Batch production and secretion kinetics of hybridomas: pulse-chase experiments. Cytotechnology 1990; 4:77-89.
336. Philips PJ, Marquis CP, Barford JP, Harbour C. Analysis of some batch and continuous kinetic data of hybridoma cells. Cytotechnology 1991; 6:189-195.
337. Bushell ME, Bell SL, Scott MF, Snell K, Spier RE, Wardel JN, Sanders PG. A three phase pattern in growth, monoclonal antibody production, and metabolite exchange in a hybridoma bioreactor culture. Biotechnol Bioeng 1993; 42:133-139.
338. Merten O-W, Palfi GE, Element G, Steindl F. Specific kinetic patterns of production of monoclonal antibodies in batch cultures and consequences on fermentation processes. In: Spier RE, Griffiths JB, eds. Modern Approaches to Animal Cell Technology. Oxford: Butterworth, 1987:381-396.
339. Noe W, Bux R, Werner RG, Berthold W. Aspects of continuous culture versus batch mode for animal cells in industrial processes. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:354-360.
340. Kadouri A, Spier RE. Some myths and messages concerning the batch and continuous culture of animal cells. Cytotechnology 1997; 24(2):89-98.
341. Dalili M, Sayles GD, Ollis D. Glutamine-limited batch hybridoma growth and antibody production: experiment and model. Biotechnol Bioeng 1990; 36:74-82.
342. Leelavatcharamas V, Emery AN, Al-Rubeal M. The effects of initial serum concentration, pH and agitation rate on cell aggregation during batch culture of Chinese hamster ovary (CHO) cells. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Oxford: Kluwer Academic Publishers, 1995:217-221.
343. Doverskog M, Bertram E, Ljunggren J, Ohman L, Sennerstam R, Haggstrom L. Cell cycle progression in serum-free cultures of Sf9 insect cells: modulation by conditioned medium factors and implications for proliferation and productivity. Biotechnol Prog 2000; 16(5):837-846.
344. Zeiser A, Elias CB, Voyer R, Jardin B, Kamen AA. On-line monitoring of physiological parameters of insect cell cultures during the growth and infection process. Biotechnol Prog 2000; 16(5):803-808.
345. Agrawal P, Koshy G, Ramseier M. An algorithm for operating a fed-batch fermentor at optimum specific-growth rate. Biotechnol Bioeng 1989; 33:115-125.
346. Ljunggren J, Haggstrom L. Catabolic control of hybridoma cells by glucose and glutamine limited fed batch cultures. Biotechnol Bioeng 1994; 44:808-818.
347. Romein B, van Londen P, Meijer JJ, Hellinga C, van Dijken JP, Luyben, KChAM. Substrate level control in fed-batch hybridoma cultures. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:434-436.
348. Robinson DK, Chan CP, Ip CY, Tsai PK, Tung I, Seamans TC, Lenny AB, Lee DK, Irwin J, Silberklang M. Characterization of recombinant antibody produced in the course of a high yield fed-batch process. Biotechnol Bioeng 1994; 44:727-735.
349. Noe W, Schorn P, Bux R, Berthold W. Fed-batch strategies for mammalian cell culture. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:413-418.
350. Dardenne M, Cherlet M, Engasser JM, Marc A. Kineteic studies of fed-batch hybridoma cultures: Effect of various feeding compositions and flow rates. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:542-544.
351. Xie L, Wang DIC. Integrated approaches to the design of media and feeding strategies for fed-batch cultures of animal cells. Trends Biotechnol 1997; 15:109-113.
352. Martinelle K, Westlund A, Haggstrom L. Ammonium ion transport-a cause of cell death. Cytotechnology 1996; 22:251-254.
353. Bibila TA, Robinson DK. In pursuit of the optimal fed-batch process for monoclonal antibody production. Biotechnol Prog 1995; 11:1-13.
354. Zhou W, Chen C-C, Buckland B, Aunins J. Fed-batch culture of recombinant NSO myeloma cells with high monoclonal antibody production. Biotechnol Bioeng 1997; 55:783-792.
355. Sauer PW, Burky JE, Wesson MC, Sternard HD, Qu L. A high-yielding, generic fedbatch cell culture process for production of recombinant antibodies. Biotechnol Bioeng 2000; 67(5):585-597.
356. Nguyen B, Jarnagin K, Williams S, Chan H, Barnett J. Fed-batch culture of insect cells:a method to increase the yield of recombinant human nerve growth factor (rhNGF) in the baculovirus expression system. J Biotechnol 1993; 31(2):205-217.
357. Haggstrom L, Ljunggren J, Ohman L. Metabolic engineering of animal cells. Ann NY Acad Sci 1996; 782:40-52.
358. Doverskog M, Ljunggren J, Ohman L, Haggstrom L. Physiology of cultured animal cells. J Biotechnol 1997; 59(1-2):103-115.
359. Bedard C, Perret S, Kamen AA. Fed-batch culture of Sf-9 cells supports 3_107 cells per ml and improves baculovirus-expressed recombinant protein yields. Biotechnol Lett 1997; 19(7):629-632.
360. Riley MR, Rhiel M, Zhou XJ, Arnold MA, Murhammer DW. Simultaneous measurement of glucose and glutamine in insect cell culture media by near infrared spectroscopy. Biotechnol Bioeng 1997; 55(1):11-15.
361. Chan LCL, Greenfield PF, Reid S. Optimizating fed-batch production of recombinant proteins using the baculovirus expression vector system. Biotechnol Bioeng 1998; 59(2):178-188.
362. Mendonca RZ, Palomares LA, Ramirez OT. An insight into insect cell metabolism through selective nutrient manipulation. J Biotechnol 1999; 72(1-2):61-75.
363. Wang SL, Bentley WE, Liu CC, Wang MY. The use of glucose to regulate pH values of culture media and increase the production of baculo virus (BmNPV) and foreign protein (HBsAg). Process Biochem 1999; 34(3):295-301.
364. Elias CB, Zeiser A, Bedard C, Kamen AA. Enhanced growth of Sf-9 cells to a maximum density of 5.2_107 cells per mL and production of beta-galactosidase at high cell density by fed batch culture. Biotechnol Bioeng 2000; 68(4):381-388.
365. Xie L, Nyberg G, Gu X, Li H, Mollborn F, Wang DIC. Gamma-interferon production and quality in stoichiometric fed-batch cultures of Chinese hamster ovary (CHO) cells under serum-free conditions. Biotechnol Bioeng 1997; 56(5):577-582.
366. Liibben H, Kretzmer G. Diauxic cell behavior enables detoxification of CHO cell culture medium during fed batch cultivation. In: Merten O-W, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordrecht:Kluwer Academic Publishers, 1998:267-271.
367. Nyberg GB, Balcarcel RR, Follstad BD, Stephanopoulos G, Wang DIC. Metabolic effects on recombinant interferon-y glycosylation in continuous culture of Chinese hamster ovary cells. Biotechnol Bioeng 1998; 62(3):336-347.
368. Andersen DC, Bridges T, Gawlitzek M, Hoy C. Multiple cell culture factors can affect the glycosylation of Ans-184 in CHO-produced tissue-type plasminogen activator. Biotechnol Bioeng 2000; 70(1):25-31.
369. Kyung Y-S, Hu W.-S. Enhanced productivity of protein C by recombinant human cells in automated fed-batch cultures. Cytotechnology 1995; 17(2):109-115.
370. Lenas P, Kitade T, Watanabe H, Honda H, Kobayashi T. Adaptive fuzzy control of nutrients concentration in fed-batch culture of mammalian cells. Cytotechnology 1997; 25(1-3):9-15.
371. Xie L, Wang DIC. High cell density and high monoclonal antibody production through medium design and rational control in a bioreactor. Biotechnol Bioeng 1996; 51:725-729.
372. Zhou W, Rehm J, Europa A, Hu W.-S. Alteration of mammalian cell metabolism by dynamic nutrient feeding. Cytotechnology 1997; 24:99-108.
373. Jo EC, Park HJ, Kim D, Moon HM. Repeated fed-batch culture of hybridoma cells in nutrient-fortified high-density medium. Biotechnol Bioeng 1993; 42:1229-1237.
374. Glacken MW, Huang C, Sinskey AJ. Mathematical descriptions of hybridoma culture kinetics. III. Simulation of fed-batch bioreactors. J Biotechnol 1989; 10:39-66.
375. Frame KK, Hu WS. Kinetic study of hybridoma cell growth in continuous culture. I. A model for non-producing cells. Biotechnol Bioeng 1991; 37:55-64.
376. Ray NG, Karkare SB, Runstadler PW. Cultivation of hybridoma cells in continuous cultures: kinetics of growth and products formation. Biotechnol Bioeng 1989; 33:724-730.
377. Martens DE, Gooijer CD, Groot CAMV, Beuvery EC. Effect of dilution rate on growth, productivity, cell cycle and size, and shear sensitivity of a hybridoma cell in a continuous culture. Biotechnol Bioeng 1993; 41:429-439.
378. Hiller GW, Aeschlimann AD, Clark DS, Blanch HW. A kinetic analysis of hybridoma growth and metabolism in continuous suspension culture on serum-free medium. Biotechnol Bioeng 1991; 38:733-741.
379. Sanfeliu A, Paredes C, Cairo JJ, Godia F. Analysis of glucose and glutamine metabolism of hybridoma cells by continuous culture experiments. In: Carrondo MJT, Griffiths JB, Moreira JLP, eds. Animal Cell Technology: From Vaccine to Genetic Medicine. Dordrecht: Kluwer Academic Publishers, 1997:785-789.
380. Cherlet M, Marc A. Intracellular pH monitoring as a tool for the study of hybridoma cell behavior in batch and continuous bioreactor cultures. Biotechnol Prog 1998; 14(4):626-638.
381. Vriezen N, Vandijken JP. Fluxes and enzyme activities in central metabolism of myeloma cells grown in chemostat culture. Biotechnol Bioeng 1998; 59(1):28-39.
382. Heidemann R, Liitkemeyer D, Bfintemeyer H, Lehmann J. Effects of dissolved oxygen levels and the role of extra- and intracellular amino acid concentrations upon the metabolism of mammalian cell lines during batch and continuous cultures. Cytotechnology 1998; 26(3):185-197.
383. Nyberg GB, Balcarcel RR, Follstad BD, Stephanopoulos GI, Wang DIC. Metabolism of peptide amino-acids by Chinese hamster ovary cells grown in a complex medium. Biotechnol Bioeng 1999; 62(3):324-335.
384. Cruz HJ, Moreira JL, Carrondo MJT. Metabolic shifts by nutrient manipulation in continuous cultures of BHK cells. Biotechnol Bioeng 1999; 66(2):104-113.
385. Europa AF, Gambhir A, Fu PC, Hu WS. Multiple steady states with distinct cellular metabolism in continuous culture of mammalian cells. Biotechnol Bioeng 2000; 67(1):25-34.
386. Follstad BD, Balcarcel RR, Stephanopoulos G, Wang DIC. Metabolic flux analysis of hybridoma continuous culture steady state multiplicity. Biotechnol Bioeng 1999; 63(6):675-683.
387. Cruz HJ, Peixoto CM, Nimtz M, Alves PM, Dias EM, Moreira JL, Carrondo MJT. Metabolic shifts do not influence the glycosylation patterns of a recombinant fusion protein expressed in BHK cells. Biotechnol Bioeng 2000; 69(2):129-139.
388. Baker KN, Rendal MH, Hills AE, Hoare M, Freedman RB, James DC. Metabolic control of recombinant protein iV-glycan processing in NSO and CHO cells. Biotechnol Bioeng 2001; 73(3):188-202.
389. Simpson NH, Singh RP, Emery AN, Al-Rubeai M. Bcl-2 over-expression reduces growth rate and prolongs Gl phase in continuous chemostat cultures of hybridoma cells. Biotechnol Bioeng 1999; 64(2):174-186.
390. Jan DCH, Petch DA, Huzel N, Butler M. The effect of dissolved oxygen on the metabolic profile of a murine hybridoma grown in serum-free medium in continuous culture. Biotechnol Bioeng 1997; 54:153-164.
391. Schmid G, Huber F, Kerschbaumer R. Adaptation of hybridoma cells to hydrodynamic stress under continuous culture conditions. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:203-205.
392. Ozturk SS, Palsson BO. Loss of antibody productivity durig long-term cultivation of a hybridoma cell line in low serum and serum free media. Hybridoma 1990; 9:167-175.
393. Frame KK, Hu WS. The loss of antibody productivity in continuous cultures of hybridoma cells. Biotechnol Bioeng 1990; 35:469-476.
394. Barnes LM, Bentley CM, Dickson AJ. Characterization of the stability of recombinant protein production in the GS-NSO expression system. Biotechnol Bioeng 2001; 73(4):261-270.
395. Morrison CJ, McMaster WR, Piret JM. Differential stability of proteolytically active and inactive recombinant metalloproteinase in Chinese hamster ovary cells. Biotechnol Bioeng 1997; 53(6):594-600.
396. Mercille S, Johnson M, Lanthier S, Kamen AA, Massie B. Understanding factors that limit the productivity of suspension-based perfusion cultures operated at high medium renewal rates. Biotechnol Bioeng 2000; 67(4):435-450.
397. De la Broise D, Noiseux M, Massie B, Lemieux R. Hybridoma perfusion systems: a comparison study. Biotechnol Bioeng 1992; 40:25-32.
398. Ozturk SS. Engineering challenges in high density cell culture systems. Cytotechnology 1996; 22(1-3):3-16.
399. Tokashiki M, Arai T, Hamamoto K, Ishimaru K. High density culture of hybridoma cells using a perfusion culture vessel with external centrifuge. Cytotechnology 1990; 3:239-244.
400. Hu WS, Peshwa MV. Animal cell bioreactors-recent advances and challenges to scaleup. Can J Chem Eng 1991; 69:409-420.
401. Runstadler PW. Perfusion versus batch culture: which is the preferred process? In: Spier RE, Griffiths JB, MacDonald C, eds Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:347-353.
402. Runstadler PW, Tung AS, Ray NG. Fluidized-bed bioreactor perfusion culture for the production of therapeutic proteins. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:495-500.
403. Bjorling T, Dudel U, Fenge C. Evaluation of a cell separator in large scale perfusion culture. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology:Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:671-675.
404. Zeng AP, Deckwer WD. Model simulation and analysis of perfusion culture of mammalian cells at high cell density. Biotechnol Prog 1999; 15(3):373-382.
405. Schmid G, Wilke CR, Blanch HW. Continuous hybridoma suspension cultures with and without cell retention: kinetics of growth, and product formation. J Biotechnol 1992; 22:31-40.
406. Banik GG, Heath CA. Partial and total cell retention in a filtration-based homogeneous perfusion reactor. Biotechnol Bioeng 1995; 11:548-588.
407. Banik GG, Heath CA. High-density hybridoma perfusion culture, limitation vs. inhibition. Appl Biochem Biotechnol 1996; 61:211-229.
408. Chisti Y. Build better industrial bioreactors. Chem Eng Prog 1992; January:55-58.
409. Gray DR. Bioreactor operations-preparation, sterilization, charging, culture initiation and harvesting. In: Spier RE, ed. Encyclopedia of Cell Technology. Vol. 1. New York:Wiley, 2000:138-174.
410. Wolf MX, Hirschel MD. Growing TIL and LAK cells in hollow fiber bioreactors. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 6. Orlando: Academic Press, 1994:237-258.
411. Threlfall G, Garland SG. Equipment sterilisation. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Orlando: Academic Press, 1985.
412. Harper GJ. Air sterilisation. In: Spier RE, Griffiths JB, eds. Animal Cell Biotechnology. Vol. 1. Orlando: Academic Press, 1985.
413. Chisti Y. Assure bioreactor sterility. Chem Eng Prog 1992; 80-85.
414. Baseman HJ. SIP=CIP validation. Pharm Eng 1992; 12(2):37-46.
415. Young JH. Sterilization of various diameter dead-ended tubes. Biotechnol Bioeng 1993; 42:125-132.
416. Chadd HE, Chamow SM. Therapeutic antibody expression technology. Curr Opin Biotechnol 2001; 12:188-194.
417. FDA: http:==www.fda.gov=.
418. EMEA: http:==www.emea.eu.int=.
419. ICH: http:==www.ifpma.org=ichl.html.
420. Current good manufacturing practice for finished pharmaceuticals, 21; C.F.R. 211. http:==www.access.gpo.gov=nara =cfr=waisidx_01=21 cfr211_01.html.
421. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs, general, 21; C.F.R. 210.http:==www.access.gpo.gov=nara=cfr=waisidx_01=21 cfr2 10_01.html.
422. CDER: http:==www.fda.gov=cder.
423. ISPE: http:==www.ispe.org=guides.htm.
424. Adamson R. Design and operation of a recombinant mammalian cell manufacturing process for rFVIII. Ann Hematol 1994; 68:9-14.
425. Teige M, Weidemann R, Kretzmer G. Problems with serum-free production of antithrombin III regarding proteolytic activity and product quality. J Biotechnol 1994; 34:101-105.
426. Kratje RB, Reiman A, Hammer I, Wagner R. Cultivation of recombinant baby hamster kidney cells in a fluidized bed bioreactor with porous borosilicate glass. Biotechnol Prog 1994; 10:410-420.
427. Chuppa S, Tsai YS, Yoon S, Shackleford S, Rozales C, Bhat R, Tsay G, Matanguihan C, Konstantinov K, Naveh D. Fermentor temperature as a tool for control of high-density perfusion cultures of mammalian cells. Biotechnol Bioeng 1997; 55(2):328-338.
428. Palermo UP, DeGraaf ME, Marotti KR, Rehberg E. Post LE Production of analytical quantities of recombinant proteins in Chinese hamster ovary cells using sodium butyrate to elevate gene expression. J Biotechnol 1991; 19:35-48.
429. Oh SKW, Vig P, Chua F, Teo WK, Yap MGS. Substantial overproduction of antibodies by applying osmotic pressure and sodium butyrate. Biotechnol Bioeng 1993; 42:601-610.
430. Fussenegger M, Mazur X, Bailey JE. A novel cytostatic process enhances the productivity of Chinese hamster ovary cells. Biotechnol Bioeng 1997; 55(6):927-939.
431. Fussenegger M, Schlatter S, Datwyler D, Mazur X, Bailey JE. Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol 1998; 16(5):468-472.
432. Mazur X, Fussenegger M, Renner WA, Bailey JE. Higher productivity of growtharrested Chinese hamster ovary cells expressing the cyclin-dependent kinase inhibitor p27. Biotechnol Prog 1998; 14:705-713.
433. NIH Classification of Human Etiologic Agents on the Basis of Hazard-NIH Guidelines on Recombinant DNA Molecules: http:==www4.od.nih. gov=oba=RAC= guidelines=appendix_b. htm.
434. WHO Laboratory Biosafety Manual: http:==www.who.int= dsa=cat98=lab8.htm.
435. Council Directive of 26 October 1998 amending Directive 90=219=EEC on the contained use of genetically modified micro-organisms, Directive 98=8 I=EC OJ L 330 5 December 1998, pp. 13-31. http:==biosafety.ihe.be=GB=Dk.Eur.GB= Cont. Use=98_81=98_8 l_TC.html.
436. Council directive of 12 October 1993 amending directive 90=679=EEC on the protection of workers from risks related to exposure to biological agents at work, Directive 93=88=EEC OJ L 268 29 October 1993, p. 71. http:==www.biosafety.be=GB= Dir.Eur.GB=Other=93_88=TC.html.
437. CEN: list and status of TC233 standards: http:== biosafety.ihe.be=CEN= CEN_List.html.
438. Miller SR, Bergman D. Biocontainment design considerations for biopharmaceutical facilities. J Indust Microbiol 1993; 11:223-234.
439. Reuveny S, Velez D, Macmillan J, Miller L. Factors affecting cell growth and monoclonal antibody production in stirred reactors. J Immunol Methods 1986; 86:53-59.
440. Rossler B, Liibben H, Kretzmer G. Temperature: a simple parameter for process optimization in fed-batch cultures of recombinant Chinese hamster ovary cells. Enzyme Microb Technol 1996; 18:423-427.
441. Jenkins N, Hovey A. Temperature control of growth and productivity in mutant Chinese hamster ovary cells synthesizing a recombinant protein. Biotechnol Bioeng 1993; 42:1029-1036.
442. Ramirez OT, Mutharasan R. The role of the plasma membrane fluidity on the shear sensitivity of hybridomas grown under hydrodynamic stress. Biotechnol Bioeng 1990; 36:911-920.
443. Ludwig A, Tomeczkowski J, Kretzmer G. Influence of the temperature on the shear stress sensitivity of adherent BHK 21 cells. Appl Microbiol Biotechnol 1992; 38:323-327.
444. Shi Y, Ryu DDY, Ballica R. Rheological properties of mammalian cell culture suspensions:hybridoma and HeLa cell lines. Biotechnol Bioeng 1993; 41:745-754.
445. Almgren A, Nilsson K, Nilsson L. Dissolved oxygen- the critical parameter at cell growth and expression of rec. protein in porous microcarrier system. Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:212-214.
446. Lim HS, Chang KH, Kim JH. Effect of oxygen partial pressure on production of animal virus (VSV). Cytotechnology 1999; 31(3):265-270.
447. Stachura ME, Lapp CA, Tyler JM, Lee YS. Medium flow rate modulates autocrineparacrine feedback of GH and PRL release by perfused GH3 cells. In Vitro Cell Dev Biol 1990; 26(5):482-492.
448. Bader A, Boker K, Knop E, Friihauf N, Oldhafer K, Ringe B, Pichlmayr R, Sewing KF. Reconstruction of liver tissue in-vitro geometry of characteristic flat bed-, hollow fiber-, and spouted bed bioreactors with reference to the in vivo liver. Artificial Organs 1995; 19:941-950.
449. Hesse F, Wagner R. Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures. Trends Biotechnol 2000; 18(4):173-180.
450. Bowen WR, Gan Q. Properties of microfiltration membranes: flux loss during constant pressure permeation of bovine serum albumin. Biotechnol Bioeng 1991; 38:688-696.
451. Mercille S, Johnson M, Lemieux R, Massie B. Filtration-based perfusion of hybridoma cultures in protein-free medium: reduction of membrane fouling by medium supplementation with DNase I. Biotechnol Bioeng 1994; 43:833-846.
452. McAdams TA, Miller WM, Papoutsakis ET. Hematopoietic cell culture therapies (Part I): cell culture considerations. Trends Biotechnol 1996; 14(9):341-349.
453. Thaler T, Vanak J. Oxygen transfer characteristics in cell culture fermenters: direct sparging-membrane oxygenation-bubble-free aeration through a rotating sieve. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:451-456.
454. Oosterhuis NMG, Thalman G, Berg GJ, Kopp TJ. Growth of mammalian cells using a new bubblefree aeration and perfusion systems: the Chemcell. Med Fac Landbouww Rijksuniv Gent 1988; 53(4a):1655-1662.
455. Takazawa Y, Tokashiki M. Production of human-mouse chimeric antibody by high cell density perfusion culture. Cytotechnology 1989; 2:95-101.
456. Stevens J, Eickel S, Onken U. Lamellar clarifier- a new device for animal cell retention in perfusion culture systems. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:234-239.
457. Thompson KJ, Wilson JS. A compact gravitational settling device for cell retention. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:227-229.
458. Wen ZY, Teng XW, Chen F. A novel perfusion system for animal cell cultures by two step sequential sedimentation. J Biotechnol 2000; 79(1):1-11.
459. Doblhoff-Dier O, Gaida T, Katinger H, Burger W, Groeschl M, Benes E. A novel ultrasonic resonance field device for the retention of animal cells. Biotechnol Prog 1994; 10:428-432.
460. Woodside SM, Bowen BD, Piret JM. Experimental and theoretical analysis of cell separations by ultrasonic forces. In: Carrondo MJT, Griffiths JB, Moreira JLP, eds. Animal Cell Technology: From Vaccine to Genetic Medicine. Dordrecht: Kluwer Academic Publishers, 1997:251-256.
461. Merten OW. Constructive improvement of the ultrasonic separation device ADI 1015. Cytotechnology 2000; 34(1):175-179.
462. Ryll T, Dutina G, Reyes A, Gunson J, Krummen L, Etcheverry T. Performance of small-scale CHO perfusion cultures using an acoustic cell filtration device for cell retention:characterization of separation efficiency and impact of perfusion on product quality. Biotechnol Bioeng 2000; 69(4):440-449.
463. Kendro. Product information Centritech Cell_. 2000.
464. Jager V. A novel perfusion system for the large-scale cultivation of animal cells based on a continuous flow centrifuge. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Processes and Products. Oxford: Butterworth-Heinemann, 1992:397-402.
465. Kamen AA. Use of the Centritech lab centrifuge for perfusion culture of hybridoma cells in protein-free medium. Biotechnol Prog 1996; 12(6):855-864.
466. Yabannavar VM, Singh V, Connelly NV. Scaleup of spinfilter perfusion bioreactor for mammalian cell retention. Biotechnol Bioeng 1994; 43:159-164.
467. Rebsamen E, Goldinger W, Scheirer W, Merten O-W, Palfi GE. Use of a dynamic filtration method for separation of animal cells. Dev Biol Stand 1987; 66:273-277.
468. Fraune E, Fenge C, Kuhlmann W, Broly H. Development of perfusion bioreactors for high density cultures. In: White M, Reuveny S, Shaferman A, eds. Biologicals from Recombinant Microorganisms and Animal Cells-Production and Recovery. Weinheim:VCH, 1990:159-164.
469. Duvar S, Muthing J, Mohr FL, Lehmann J. Scale up cultivation of primary human umbilical vein endothelial cells on macrocarriers from spinner vessels to bioreactor fermentation. Cytotechnology 1996; 21(1):61-72.
470. Werner A, Duvar S, Miithing I, Btintemeyer H, Ltinsdorf H, Strauss M, Lehmann J. Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers. Biotechnol Bioeng 2000; 68(1):59-70.
471. Martin N, Brennan A, DeNome L, Shaevitz J. High productivity in mammalian cell culture. Biotechnology 1987; 5:838-840.
472. Kloppinger M, Freitag G, Fraune E, Miltenburger HG. Flow cytometric process monitoring of hybridoma cells in batch and perfusion culture. In: Spier RE, Grififths JB, Stephenne J, Crooy PJ, eds. Advances in Animal Cell Biology and Technology for Bioprocesses. Oxford: Butterworth, 1989:125-128.
473. Goebel NK, Kuehn R, Flickinger C. Methods for determination of growth-rate-dependent changes in hybridoma volume, shape and surface structure during continuous recycle. Cytotechnology 1990; 4:45-57.
474. Winzeler HB. Membran-Filtration mit hoher Trennleistung und minimalem Energiebedarf. Chimia 1990; 44:288-291.
475. Pinton H, Silva AL, Goergen JL, Marc A, Engasser JM, Rabaud JN, Pierry G. Control of the maximal cell density in a membrane perfusion reactor. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:470-475.
476. Goergen JL, da Silva AL, Marc A, Engasser JM. Fast propagation of hybridoma cells in a forced-flow membrane perfusion reactor. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht:Kluwer Academic Publishers, 1995:705-710.
477. Zumbusch Pv, Portner R, Brun B, Brunner G, Markl H. On the use of electric fields to prevent membrane fouling of process integrated cross flow filtration at hybridoma cell culture. In: Carrondo MJT, Griffiths JB, Moreira JLP, eds. Animal Cell Technology:From Vaccine to Genetic Medicine. Oxford: Kluwer Academic Publishers, 1997:215-220.
478. Vogel JH, Kroner KH. Controlled shear filtration: A novel technique for animal cell separation. Biotechnol Bioeng 1999; 63(6):663-674.
479. Marique T, Paul T, Blankaert D, Guerra IT, Werenne J. Collagenase production by a cell line in collagen microspheres in a fluidized-bed reactor and its modelization. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:245-247.
480. Marique TH, Malarme D, Stragier P, Werenne J. On-line monitoring of growth and viral infection of VERO cells in collagen microspheres in a fluidized-bed bioreactor. In: Spier RE, Griffiths IB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:369-371.
481. Shen BQ, Greenfield PF, Reid S. Calcium alginate immobilized hybridomas grown using a fluidized-bed perfusion system with a protein-free medium. Cytotechnology 1994; 14:109-117.
482. Keller J, Dunn IJP, Heinzle E. Improved performance of the fluidized-bed reactor for the cultivation of animal cells. In: Spier RE, Griffiths IB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:513-515.
483. Kratje RB, Wagner R. Evaluation of production of recombinant human interleukin-2 in fluidized bed bioreactor. Biotechnol Bioeng 1992; 39:233-242.
484. Kratje R, Wagner R. The production of recombinant human interleukin-2 in a fluidized bed bireactor. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology:Developments, Processes and Products. Oxford: Butterworth-Heinemann, 1992:488-494.
485. Preissmann A, Wiesmann R, Buchholz R, Werner RG, Noe W. Investigations on oxygen limitations of adherent cells growing on macroporous microcarriers. Cytotechnology 1997; 24(2):121-134.
486. Kawakubo Y, Matsushita T, Funatsu K. Tissue plasminogen activator (t-PA) production by a high density culture of weakly adherent human embryonic kidney cells using a polyurethan-foam packed-bed culture system. Appl Microbiol Biotechnol 1994; 41:413-418.
487. Heine H, Spies M, Wandrey C. Effects of ammonium and lactate during continuous hybridoma fermentations in a fluidized-bed bioreactor. In: Merten O-W, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordercht: Kluwer Academic Publishers, 1998:281-283.
488. Heine H, Biselli M, Wandrey C. High cell density cultivation of hybridoma cells: spin filter vs immobilised culture. In: Bernard A, Griffiths B, Noe W, Wurm F, eds. Animal Cell Technology: Products from Cells-Cells as Products. Oxford: Butterworth-Heinemann, 1999:83-85.
489. Reuschenbach P. Production of t-PA by C127 cells cultivated on different porous microcarrier in a perfused fluidized bed reactor. Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Processes and Products. Oxford: Butterworth-Heinemann, 1992:511-513.
490. Kong D, Cardak S, Chen M, Gentz R, Zhang J. High cell density and productivity culture of Chinese hamster ovary cells a fluidized bed bioreactor. Cytotechnology 1999; 29(3):215-220.
491. Bluml G, Gaida TH, Zach N, Assadian A, Schmatz C, Katinger H. Fluidized bed technology:Influence of fluidization velocity on nutrient consumption and product expression. In: Merten OW, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordrecht: Kluwer Academic Publishers, 1998:385-387.
492. Wang MD, Yang M, Huzel N, Butler M. Erythropoetin production from CHO cells grown in a fluidized-bed bioreactor with macroporous beads. In: Bernard A, Griffiths B, Noe W, Wurm F, eds. Animal Cell Technology: Products from Cells-Cells as Products; 1999:307-309.
493. Muller D, Unterluggauer F, Kreismayr G, Schmatz C, Assadian A, Wiederkum S, Preis S, Vorauer-Uhl K, Doblhoff-Dier O, Katinger H. Continuous perfused fluidized bed technology, increased productivities and product concentration. In: Bernard A, Griffiths B, Noe W, Wurm F, eds. Animal Cell Technology: Products from Cells, Cells as Products. Oxford: Butterworth-Heinemann, 1999:319-321.
494. Valle MA, Kaufman J, Bentley WE, Shiloach J. Evaluation of porous microcarriers in fluidized bed reactors for protein production by HEK 293 cells. In: Merten O-W, Perrin B, Griffiths B, eds. New Developments and New Applications in Animal Cell Technology. Dordrecht: Kluwer Academic Publishers, 1998:381-384.
495. Unterluggauer F, Doblhoff O, Reiter M, Bluml G, Zach N, Krai G, Schmatz G, Katinge H. Scale-up of fluidized bed reactor operated with porous glass carriers. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Processes and Products. Oxford: Butterworth-Heinemann, 1992:505-507.
496. Loibner AP, Zach N, Doblhoff-Dier O, Reiter M, Bayer M, Katinger H. On-line glucose control of animal cell cultures in fluidized bed. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford:Butterworth-Heinemann, 1994:372-375.
497. Reiter R, Bliiml G, Gaida T, Zach N, Schmatz C, Borth N, Hohenwarter O, Katinger H. High density aggregate culture of recombinant cho cells in fluidized bed. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann:421-423.
498. Racher AJ, Looby D, Griffiths JB. Metabolite parameter modulating mab production in a fixed bed, glass sphere bioreactor. In: Spier RE, Griffiths JB, MacDonald C, eds. Animal Cell Technology: Developments, Process and Products. Oxford: Butterworth-Heinemann, 1992:455-559.
499. Ludemann I, Portner R, Schaefer C, Schick K, Sramkova K, Reher K, Neumaier M, Franek F, Markl, H. Improvement of the culture stability of non-anchorage-dependent animal cells grown in serum-free media through immobilization. Cytotechnology 1996; 19(2):111-124.
500. Clarke JB, Griffiths JB. Bioreactors for production of HIV- a comparative evaluation of flask, suspension and fixed bed cultures. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:519-522.
501. Portner R, Bohmann A, Markl H. Application of dialysis techniques for effective production of biologicals with immobilized animal cells. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:823-827.
502. Fassnacht D, Portner R. Experimental and theoretical considerations on oxygen supply for animal cell growth in fixed-bed reactors. J Biotechnol 1999; 72(3):169-184.
503. Jannin J, Gaspard C, Zaot C, Fraue T, Dhainaut F, Mignot, G. Comparison of two systems based on porous beads for the production of recombinant von Willebrand factor by CHO cells. In: Spier RE, Griffiths JB, Meignier B, eds. Production of Biologicals from Animal Cells in Culture. Oxford: Butterworth-Heinemann, 1991:525-527.
504. Clarke JB, Griffiths JB. The effect of bioreactor configuration on production of HIV and cell-virus interaction. Cytotechnology 1990; 4(2):145-153.
505. Racher AJ, Griffiths JB. Development of a bioreactor process for recombinant cell lines. In: Spier RE, Griffiths JB, Berthold W, eds. Animal Cell Technology: Products of Today, Prospects for Tomorrow. Oxford: Butterworth-Heinemann, 1994:248-251.
506. Schroder B, Herfurth C, Meilkier P, Link H, Wandrey C. Differentiation of bone marrow cells immobilized on microcarriers in a fluidized bed reactor. In: Carrondo MJT, Griffiths JB, Moreira JLP, eds. Animal Cell Technology: From Vaccine to Genetic Medicine. Dordrecht: Kluwer Academic Publishers, 1997:589-593.
507. Preissmann A, Bux R, Schorn P, Noe W. Comparative study for the propagation of anchorage-dependent cells using different forms macroporous carriers. In: Beuvery EC, Griffiths JB, Zeijlemaker WP, eds. Animal Cell Technology: Developments Towards the 21st Century. Dordrecht: Kluwer Academic Publishers, 1995:841-845.
508. Grabner R, Paul E. Use of motionless mixer as cell culture propagat. US 4, 296, 204, October 20, 1981.
509. Lazar A, Reuveny S, Kronman C, Velan B, Shafferman A. Evaluation of anchoragedependent cell propagation systems for production of human acetylcholinesterase by recombinant 293 cells. Cytotechnology 1993; 13(2):115-123.
510. Matsushita T, Hidaka H, Kamihata K, Kawakubo Y, Funatsu K. High density culture of anchorage-dependent animal cells by polyurethane foam packed-bed culture systems. Appl Microbiol Biotechnol 1991; 35:159-164.
511. Lazar A. Immobilisation of animal cells in fixed bed reactors. Biotech Adv 1991; 9:411-424.
512. Treat JC, Sandelin KK, Beiderman BC, Kirschner RJ. Low-and high-producing animal cells cultures in perfused, packed beds of non-woven fabric. In: Carrondo MJT, Griffiths JB, Moreira JLP, eds. Animal Cell Technology: From Vaccine to Genetic Medicine. Dordrecht: Kluwer Academic Publishers, 1997:313-318.
513. Kadouri A, Wang G, Zhang W, Jacklin C, Freedman D. Design and performance of perfusion based packed bed bioreactor for the production of secreted protein. In: Animal Cell Technology: from Vaccine to Genetic Medicine. Kluwer Academic Publishers, 1997:307-312.
514. Park S, Stephanopoulos G. Packed bed bioreactor with porous ceramic beads for animal cell culture. Biotechnol Bioeng 1993; 41:25-34.
515. Thewall PE, Brindle KM. Analysis of CHO-K1 cell growth in a fixed bed bioreactor using magnetic resonance spectroscopy and imaging. Cytotechnology 1999; 30:121-132